Eli Lilly’s Most Promising Weight Loss Drug May Come With a Surprising Benefit: Pain Relief
Key Points Retatrutide’s recent trial results suggest it may be even better than Eli Lilly’s already approved GLP-1 medication, tirzepatide. Besides weight loss, retatrutide helped many people with osteoarthritis in their knees feel completely pain-free by the end of the study. GLP-1 products have been huge catalysts for Eli Lilly’s growth in recent quarters, and […]
FDA asks that suicide warning labels be taken off GLP-1 weight-loss drugs
The Food and Drug Administration said Tuesday that it wants suicide warning labels on GLP-1 weight-loss drugs to be removed.
Mission Foods: NEW YEAR, NEW NUTRITION PLAN!
From GLP-1 to Keto, hear the nutrition tips and recipes you need to stay on track in the New Year IRVING, Texas, Jan. 14, 2026 /PRNewswire/ — BACKGROUND: As the calendar turns from December to January, millions of Americans vow that this will be the year they stick to their New Year’s…
Compounding pharmacy sues Lilly, Novo over GLP-1 drug competition
Post Content
Day 2 @ JP Morgan in Obesity Drugs and Therapies
Here are the **highlights from Day 2 of the JP Morgan Healthcare Conference (San Francisco) specifically related to obesity, weight-gain therapies, and related drug developments Fierce PharmaPharmaceutical TechnologyReutersFierce BiotechPharmaceutical Technology 🧪 New & Emerging TherapiesAmgen’s MariTide weight-loss programAmgen touted positive data on its experimental obesity drug MariTide, showing the therapy helped trial participants maintain significant […]
Day 1 @ JP Morgan in Obesity Drugs and Therapies
JP Morgan 2026: Obesity & GLP-1 Therapies Take Center StageWhat the Latest Deals and Data Mean for the Future of Metabolic MedicineThe J.P. Morgan Healthcare Conference once again served as the bellwether for where biotech and pharma are headed—and in 2026, GLP-1 and obesity therapeutics dominated the conversation.From next-generation incretin drugs to RNA-based obesity targets […]
Food Companies Are Targeting Users of Weight-Loss Drugs With ‘GLP-1 Friendly’ Labels
But the labels — unlike the popular medications themselves — aren’t regulated by the FDA.
Oprah and Serena Williams Team Up to Promote the Joys of Weight Loss Drugs
Oprah Winfrey recently hosted an event for her podcast dedicated to the topic of GLP-1 medications, a.k.a. weight loss drugs such as Ozempic. Winfrey had opened up about using the medication in 2023 and how it changed her life, and… Read more…
Glucagon-like peptide-1 receptor agonists for obesity: Growing popularity met with growing questions over safety
by Ariana M. Chao, Adam Gilden, Thomas A. Wadden Glucagon-like peptide-1 (GLP-1)-based medications, such as semaglutide and tirzepatide, have transformed obesity care. However, rising use brings concerns about side effects, long-term outcomes, and unregulated products. Ensuring safe access requires oversight, monitoring, and coordinated clinical care. In this Perspective, Ariana Chao, Adam Gilden and Thomas Wadden […]
Eli Lilly’s Most Promising Weight Loss Drug May Come With a Surprising Benefit: Pain Relief
The rising popularity of weight loss drugs is a key reason healthcare company Eli Lilly (NYSE: LLY) has been soaring in value in recent years. It has a leading GLP-1 drug that’s approved for diabetes (Mounjaro) and weight loss (Zepbound). Those products are generating billions in revenue for the business every quarter. What’s encouraging, however, […]